A Review Of ABBV-744 in combination with immunotherapy
Interventional studies tend to be prospective and are particularly tailored To judge direct impacts of treatment or preventive measures on disease.- "Our study disclosed the crucial role of the KLF16/MYC regulatory axis in modulating tumor growth and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, such as OTX015